Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 596

    1.

    Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis.

    Lattif AA, K Mukherjee P, Chandra J, Swindell K, Lockhart SR, Diekema DJ, Pfaller MA, Ghannoum MA.

    Int J Med Microbiol. 2009 Nov 19. [Epub ahead of print]PMID: 19932053 [PubMed - as supplied by publisher]Related articles

    2.

    Wild-type MIC Distributions and Epidemiological Cutoff Values (ECVs) for the Echinocandins and Candida spp.

    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J, Diekema DJ.

    J Clin Microbiol. 2009 Nov 18. [Epub ahead of print]PMID: 19923478 [PubMed - as supplied by publisher]Related articles

    3.

    Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay.

    Etienne KA, Gade L, Lockhart SR, Diekema DJ, Messer SA, Pfaller MA, Balajee SA.

    J Clin Microbiol. 2009 Dec;47(12):4171-2. Epub 2009 Sep 30.PMID: 19794043 [PubMed - in process]Related articles

    4.

    Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

    Pfaller MA, Messer SA, Georgopapadakou N, Martell LA, Besterman JM, Diekema DJ.

    J Clin Microbiol. 2009 Dec;47(12):3797-804. Epub 2009 Sep 30.PMID: 19794038 [PubMed - in process]Related articles

    5.

    Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.

    Siikala E, Richardson M, Pfaller MA, Diekema DJ, Messer SA, Perheentupa J, Saxén H, Rautemaa R.

    Int J Antimicrob Agents. 2009 Dec;34(6):607-9. Epub 2009 Sep 11. No abstract available. PMID: 19748230 [PubMed - in process]Related articles

    6.

    In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

    Diekema DJ, Messer SA, Boyken LB, Hollis RJ, Kroeger J, Tendolkar S, Pfaller MA.

    J Clin Microbiol. 2009 Oct;47(10):3170-7. Epub 2009 Aug 26.PMID: 19710283 [PubMed - in process]Related articles

    7.

    In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.

    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.

    J Clin Microbiol. 2009 Oct;47(10):3323-5. Epub 2009 Aug 26.PMID: 19710267 [PubMed - in process]Related articles

    8.

    Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.

    Pfaller MA, Diekema DJ, Ghannoum MA, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Espinel-Ingroff A, Fowler CL, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Sheehan DJ, Walsh TJ; Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee.

    J Clin Microbiol. 2009 Oct;47(10):3142-6. Epub 2009 Aug 19.PMID: 19692559 [PubMed - in process]Related articles

    9.

    Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ; ARTEMIS DISK Global Antifungal Surveillance Group.

    Diagn Microbiol Infect Dis. 2009 Sep;65(1):27-34.PMID: 19679232 [PubMed - indexed for MEDLINE]Related articles

    10.

    Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

    Pfaller MA, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Diekema DJ.

    J Clin Microbiol. 2009 Oct;47(10):3185-90. Epub 2009 Aug 5.PMID: 19656983 [PubMed - in process]Related articles

    11.

    Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.

    Clin Infect Dis. 2009 Jun 15;48(12):1695-703.PMID: 19441981 [PubMed - indexed for MEDLINE]Related articles

    12.

    Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.

    Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ; PATH Alliance.

    Diagn Microbiol Infect Dis. 2009 Jun;64(2):152-7. Epub 2009 Apr 18.PMID: 19376667 [PubMed - indexed for MEDLINE]Related articles

    13.

    Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

    Lockhart SR, Messer SA, Gherna M, Bishop JA, Merz WG, Pfaller MA, Diekema DJ.

    J Clin Microbiol. 2009 Apr;47(4):1216-7. Epub 2009 Feb 4.PMID: 19193845 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

    Diekema DJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Jones RN, Pfaller MA.

    Diagn Microbiol Infect Dis. 2009 Feb;63(2):233-6. Epub 2008 Dec 12.PMID: 19070452 [PubMed - indexed for MEDLINE]Related articles

    15.

    Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.

    Lockhart SR, Messer SA, Pfaller MA, Diekema DJ.

    J Clin Microbiol. 2009 Jan;47(1):242-4. Epub 2008 Nov 26.PMID: 19036938 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M; Global Antifungal Surveillance Group.

    J Clin Microbiol. 2009 Jan;47(1):117-23. Epub 2008 Nov 12.PMID: 19005141 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.

    Ostrosky-Zeichner L, Rex JH, Pfaller MA, Diekema DJ, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ.

    Antimicrob Agents Chemother. 2008 Nov;52(11):4175-7. Epub 2008 Sep 22.PMID: 18809944 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program.

    Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.

    J Clin Microbiol. 2008 Nov;46(11):3585-90. Epub 2008 Sep 10.PMID: 18784314 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model.

    Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J.

    Antimicrob Agents Chemother. 2008 Oct;52(10):3497-503. Epub 2008 Jul 14.PMID: 18625768 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois.

    Wrobel L, Whittington JK, Pujol C, Oh SH, Ruiz MO, Pfaller MA, Diekema DJ, Soll DR, Hoyer LL.

    Eukaryot Cell. 2008 Sep;7(9):1475-86. Epub 2008 Jul 11.PMID: 18621922 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

    Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, Chaturvedi V, Ghannoum MA, Knapp CC, Sheehan DJ, Walsh TJ.

    J Clin Microbiol. 2008 Aug;46(8):2620-9. Epub 2008 Jun 25.PMID: 18579718 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.

    Lockhart SR, Messer SA, Pfaller MA, Diekema DJ.

    J Clin Microbiol. 2008 Aug;46(8):2659-64. Epub 2008 Jun 18.PMID: 18562582 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.

    Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ.

    J Clin Microbiol. 2008 Aug;46(8):2568-72. Epub 2008 Jun 18.PMID: 18562581 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.

    Pfaller MA, Chaturvedi V, Diekema DJ, Ghannoum MA, Holliday NM, Killian SB, Knapp CC, Messer SA, Miskov A, Ramani R.

    J Clin Microbiol. 2008 Jul;46(7):2155-9. Epub 2008 May 7.PMID: 18463213 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.

    Chaturvedi V, Ramani R, Ghannoum MA, Killian SB, Holliday N, Knapp C, Ostrosky-Zeichner L, Messer SA, Pfaller MA, Iqbal NJ, Arthington-Skaggs BA, Vazquez JA, Sein T, Rex JH, Walsh TJ.

    Antimicrob Agents Chemother. 2008 Apr;52(4):1500-2. Epub 2008 Jan 28.PMID: 18227180 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ng KP, Colombo A, Finquelievich J, Barnes R, Wadula J; Global Antifungal Surveillance Group.

    J Clin Microbiol. 2008 Mar;46(3):842-9. Epub 2008 Jan 16.PMID: 18199791 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.

    Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ.

    J Clin Microbiol. 2008 Feb;46(2):551-9. Epub 2007 Dec 19.PMID: 18094129 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Nagy E, Dobiasova S, Rinaldi M, Barton R, Veselov A; Global Antifungal Surveillance Group.

    J Clin Microbiol. 2008 Feb;46(2):515-21. Epub 2007 Dec 12.PMID: 18077633 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.

    Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J.

    Antimicrob Agents Chemother. 2008 Feb;52(2):539-50. Epub 2007 Dec 10.PMID: 18070979 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ.

    J Clin Microbiol. 2008 Jan;46(1):150-6. Epub 2007 Nov 21. Erratum in: J Clin Microbiol. 2008 Sep;46(9):3184-5. PMID: 18032613 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.

    Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, Diekema DJ.

    Diagn Microbiol Infect Dis. 2008 Mar;60(3):273-7. Epub 2007 Nov 19.PMID: 18024053 [PubMed - indexed for MEDLINE]Related articles

    33.

    Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections.

    Lockhart SR, Messer SA, Pfaller MA, Diekema DJ.

    J Clin Microbiol. 2008 Jan;46(1):374-6. Epub 2007 Oct 24.PMID: 17959765 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.
    35.

    The yeast connection: is Candida linked to breastfeeding associated pain?

    Andrews JI, Fleener DK, Messer SA, Hansen WF, Pfaller MA, Diekema DJ.

    Am J Obstet Gynecol. 2007 Oct;197(4):424.e1-4.PMID: 17904988 [PubMed - indexed for MEDLINE]Related articles

    36.

    Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

    Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D.

    Diagn Microbiol Infect Dis. 2007 Dec;59(4):407-14. Epub 2007 Sep 20.PMID: 17888614 [PubMed - indexed for MEDLINE]Related articles

    37.

    Preventing the airborne spread of Staphylococcus aureus by persons with the common cold: effect of surgical scrubs, gowns, and masks.

    Bischoff WE, Tucker BK, Wallis ML, Reboussin BA, Pfaller MA, Hayden FG, Sherertz RJ.

    Infect Control Hosp Epidemiol. 2007 Oct;28(10):1148-54. Epub 2007 Aug 29.PMID: 17828691 [PubMed - indexed for MEDLINE]Related articles

    38.

    Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates.

    Zhao X, Oh SH, Jajko R, Diekema DJ, Pfaller MA, Pujol C, Soll DR, Hoyer LL.

    Fungal Genet Biol. 2007 Dec;44(12):1298-309. Epub 2007 Jun 2.PMID: 17625934 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Does one voriconazole breakpoint suit all Candida species?

    Arendrup MC, Denning DW, Pfaller MA, Diekema DJ, Rex JH.

    J Clin Microbiol. 2007 Jun;45(6):2093; author reply 2094. No abstract available. PMID: 17548458 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.

    Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, Rinaldi MG, Schell W, Walsh TJ.

    J Clin Microbiol. 2007 Jul;45(7):2180-2. Epub 2007 May 2.PMID: 17475760 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E; Global Antifungal Surveillance Study.

    J Clin Microbiol. 2007 Jun;45(6):1735-45. Epub 2007 Apr 18.PMID: 17442797 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.

    Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL, Wang A.

    J Clin Microbiol. 2007 Jun;45(6):1811-20. Epub 2007 Apr 11.PMID: 17428932 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Oral beta-lactams in the treatment of acute otitis media.

    Block SL, Doern GV, Pfaller MA.

    Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):19S-30S. Review.PMID: 17349460 [PubMed - indexed for MEDLINE]Related articles

    44.

    Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles.

    Sader HS, Bhavnani SM, Ambrose PG, Jones RN, Pfaller MA.

    J Chemother. 2007 Feb;19(1):38-43.PMID: 17309849 [PubMed - indexed for MEDLINE]Related articles

    45.

    Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.

    Diekema DJ, Messer SA, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, Pfaller MA.

    J Clin Microbiol. 2007 Jun;45(6):1974-7. Epub 2007 Feb 14.PMID: 17301284 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Oral beta-lactams in the treatment of acute bacterial rhinosinusitis.

    Hadley JA, Pfaller MA.

    Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):47S-54S. Epub 2007 Feb 9. Review.PMID: 17292580 [PubMed - indexed for MEDLINE]Related articles

    47.

    Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.

    Messer SA, Diekema DJ, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, Pfaller MA.

    J Clin Microbiol. 2007 Apr;45(4):1322-4. Epub 2007 Jan 31.PMID: 17267623 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).

    Pfaller MA, Sader HS, Jones RN.

    Diagn Microbiol Infect Dis. 2007 Apr;57(4):459-65. Epub 2007 Jan 19.PMID: 17240105 [PubMed - indexed for MEDLINE]Related articles

    49.

    Epidemiology of invasive candidiasis: a persistent public health problem.

    Pfaller MA, Diekema DJ.

    Clin Microbiol Rev. 2007 Jan;20(1):133-63. Review.PMID: 17223626 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.

    Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG.

    J Clin Microbiol. 2007 Mar;45(3):796-802. Epub 2007 Jan 10.PMID: 17215344 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...